BIVV020 (SAR445088) in Prevention and Treatment of Antibody-mediated Rejection (AMR)

BIVV020 (SAR445088)OngoingActive not recruitingPhase 2Open NCT05156710 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…